Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Bupivacaine

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 4 (2)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05732532Phase 4Completed

Steroids in Occipital Nerve Block for Treatment of Headache

NCT06764433Not ApplicableCompleted

Greater Occipital Nerve Pulsed Radiofrequency in Cervicogenic Headache

NCT03951649Phase 4Completed

Acute Headache Treatment in Pregnancy: Occipital Nerve Block vs PO Acetaminophen With Caffeine

Showing all 3 trials

Research Network

Common Treatments

  • Bupivacaine1
  • Occipital Nerve Block1
  • Greaterlesser Occipital Nerve Blocks1
  • Gonprf1
  • Lidocaine1

Active Sponsors

  • Ankara City Hospital Bilkent1
  • Mayo Clinic1
  • University of Alabama at Birmingham1

Top Investigators

Related Conditions

  • Headache3
  • Cervicogenic Headache1
  • Pregnancy Related1
  • Pulsed Radiofrequency1

Activity Timeline